Skip to main content
Contact Us
Subscribe
E-Edition
55°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Better Therapeutics Inc
(NQ:
BTTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Mar 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
0.0360 (500)
Ask (Size)
0.0370 (3)
Prev. Close
0.0446
Today's Range
N/A - N/A
52wk Range
0.0308 - 0.2725
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Friday's After-Market Session
March 15, 2024
Via
Benzinga
Why Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 15, 2024
Shares of Jabil Inc. (NYSE: JBL) fell sharply during Friday’s session after the company reported financial second-quarter results and issued FY25 guidance below estimates.
Via
Benzinga
Performance
More News
Read More
12 Health Care Stocks Moving In Friday's Intraday Session
March 15, 2024
Via
Benzinga
Nasdaq Down Over 100 Points; Hibbett Reports Downbeat Sales
March 15, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 15, 2024
Via
Benzinga
Why Cardlytics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
March 15, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
March 15, 2024
Via
InvestorPlace
Dow Dips Over 100 Points; Dick's Sporting Goods Earnings Top Views
March 14, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 14, 2024
Via
Benzinga
Crude Oil Moves Higher; Dollar General Posts Upbeat Earnings
March 14, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq
March 14, 2024
From
Better Therapeutics, Inc.
Via
Business Wire
Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers
March 05, 2024
From
Better Therapeutics, Inc.
Via
Business Wire
Better Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
March 04, 2024
From
Better Therapeutics, Inc.
Via
Business Wire
Better Therapeutics Follows Up Wins Including FDA Authorization For AspyreRx In 2023 With Securing FDA Breakthrough Device Designation Targeting Advanced Liver Disease
February 26, 2024
Via
News Direct
Exposures
Product Safety
Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 20, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 20, 2024
Via
Benzinga
Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease
February 20, 2024
From
Better Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
February 12, 2024
Via
Benzinga
Better Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes Treatment
February 06, 2024
From
Better Therapeutics Inc.
Via
Business Wire
Better Therapeutics Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx is More Effective and Less Costly than Standard of Care Alone
January 17, 2024
From
Better Therapeutics Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 11, 2024
Via
Benzinga
Better Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United States
January 04, 2024
From
Better Therapeutics
Via
Business Wire
Why LumiraDx Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket
January 02, 2024
Via
Benzinga
Better Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver Disease
January 02, 2024
From
Better Therapeutics, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
